Compare IQ & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IQ | ALVO |
|---|---|---|
| Founded | 2009 | 2013 |
| Country | China | Luxembourg |
| Employees | N/A | 1032 |
| Industry | Consumer Electronics/Video Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2017 | N/A |
| Metric | IQ | ALVO |
|---|---|---|
| Price | $1.24 | $3.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $2.91 | ★ $9.25 |
| AVG Volume (30 Days) | ★ 10.4M | 639.7K |
| Earning Date | 02-26-2026 | 03-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.57 | $20.22 |
| Revenue Next Year | $3.79 | $37.22 |
| P/E Ratio | ★ N/A | $18.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.23 | $3.45 |
| 52 Week High | $2.76 | $11.85 |
| Indicator | IQ | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 19.79 | 40.03 |
| Support Level | N/A | $3.65 |
| Resistance Level | $2.16 | $4.17 |
| Average True Range (ATR) | 0.08 | 0.19 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 1.06 | 50.52 |
Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.